Internal Medicine, Cardiovascular Disease · Livonia, MI
NPI
1053391920
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
17880 Farmington Rd
Livonia, MI, 48152
Phone (248) 615-7300
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
2,780 services
Medicare patients, 2024
425
Average age 75
Drug cost, 2024
$3.6M
18,414 prescriptions
Company payments, 2025
$3,084
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Rasak was code 99214 (office e&m - established), 926 times for 389 patients. In total Mark A Rasak billed 2,780 services in 57 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 926 | 389 | $97.05 | $90K |
| 93000 Electrocardiogram | Office | 323 | 270 | $10.90 | $3,522 |
| 93306 Echocardiography (TTE/TEE) | Office | 282 | 277 | $144.00 | $41K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 236 | 236 | $140.32 | $33K |
| 99215 Office E&M - Established | Office | 212 | 154 | $134.43 | $29K |
| 85610 Clinical Chemistry | Office | 134 | 14 | $4.20 | $563 |
| 93793 Care Management/Coordination | Office | 114 | 13 | $8.38 | $955 |
| 99406 Behavioral Health Services | Office | 64 | 33 | $15.65 | $1,002 |
| 93280 External Electrocardiographic Monitoring | Office | 49 | 31 | $26.60 | $1,303 |
| 99204 Office E&M - New | Office | 31 | 31 | $118.70 | $3,680 |
| 99223 Hospital E&M - Initial | Facility | 28 | 23 | $144.01 | $4,032 |
| 93244 Electrocardiogram | Office | 26 | 26 | $17.08 | $444 |
| 93242 Electrocardiogram | Office | 26 | 26 | $7.95 | $207 |
| 93970 Duplex Scan - Extremity Veins | Office | 22 | 22 | $150.93 | $3,321 |
| 93923 Duplex Scan - Extremity Arteries | Office | 22 | 22 | $99.23 | $2,183 |
By year: 2022 $288K for 3,232 services; 2023 $239K for 2,932 services; 2024 $236K for 2,780 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 134 | 14 | $4.20 | $563 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Rasak prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,062 prescriptions and refills. In total Mark A Rasak wrote 18,414 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,062 | 2,836 | 287 | $15K |
| Amlodipine Besylate Generic | 759 | 2,052 | 215 | $6,168 |
| Xarelto Rivaroxaban | 665 | 1,407 | 162 | $751K |
| Metoprolol Succinate Generic | 641 | 1,768 | 177 | $13K |
| Clopidogrel Clopidogrel Bisulfate | 511 | 1,395 | 136 | $9,868 |
| Eliquis Apixaban | 464 | 890 | 115 | $497K |
| Rosuvastatin Calcium Generic | 456 | 1,255 | 139 | $8,198 |
| Carvedilol Generic | 441 | 1,072 | 116 | $5,308 |
| Losartan Potassium Generic | 407 | 1,031 | 120 | $4,806 |
| Pantoprazole Sodium Generic | 398 | 1,073 | 125 | $8,608 |
| Ezetimibe Generic | 386 | 1,055 | 118 | $10K |
| Alprazolam Generic | 365 | 371 | 68 | $2,660 |
| Metoprolol Tartrate Generic | 358 | 973 | 109 | $3,696 |
| Lisinopril Generic | 335 | 963 | 96 | $3,392 |
| Omeprazole Generic | 311 | 764 | 87 | $4,839 |
Brand drugs: 3,043 claims; generic drugs: 15,241 claims; opioid claims: 213.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Rasak $3,084 ($3,084 in general payments such as food, travel and fees) from 17 companies. The largest payer was Lantheus Medical Imaging, Inc. with $1,387.
| Company | Payments | Amount |
|---|---|---|
| Lantheus Medical Imaging, Inc. LNTH | 2 | $1,387 |
| Alnylam Pharmaceuticals Inc. ALNY | 10 | $320 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $272 |
| Merck Sharp & Dohme LLC MRK | 12 | $210 |
| Pfizer Inc. PFE | 8 | $142 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $137 |
| Novo Nordisk Inc NVO | 6 | $136 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $121 |
| Scpharmaceuticals Inc. SCPH | 3 | $71.7 |
| Abbvie Inc. ABBV | 3 | $56.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.